GovChime
AWARDPURCHASE ORDERSmall business

Purchase order 75N95022P00288LIFELINE CELL TECHNOLOGY, LLC

Overview

Award facts

Net obligations
$68.87K
$68,872of $68.87K potential value
Outlays (paid to date)
$9.23K
$9.23K paid of $68.87K obligated$9,229
Period of performance
Jun 2, 2022 to Jul 1, 2022
Ended
Modifications
1
Latest action Mar 20, 2023
Contract type
Purchase order
PIID 75N95022P00288

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

HUMAN SMALL AIRWAY EPITHELIAL CELLS

Dates and value

Award date
Signed on Jun 2, 2022
Potential end of performance
Jun 30, 2022
Current value
$68,872Base and exercised options
Potential value (if all options are exercised)
$68,872

Obligations by fiscal year of action

  • FY2022: $68,872

Total across 1 fiscal year: $68,872

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Mar 20, 2023. View on USAspending · Recipient on SAM.gov

Recipient

LocationFREDERICK, MD
UEITVSAANLAZFY3
CAGE code4QA16
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt

Business types and certifications

For-profit organizationLimited liability companyCorporation (not tax-exempt)Manufacturer of goods

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIDA
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NCATS
Funded from
National center for advancing translational sciences (0875)Program activities075-0875Federal accounts (agency financial reports)

Place of performance

Place of performance
Frederick, Maryland 21701-4763
Congressional district (place of performance)
MD-06As reported at the time of the action

Classification and competition

Classification

Product or service (PSC)
6505DRUGS AND BIOLOGICALS (product)

Competition

Extent competed
Not competedC
Reason not competed
Only one source-other (FAR 6.302-1 other)ONE
Solicitation procedures
Only one sourceSSS
Set-aside
No set-aside used
Contract pricing
Firm fixed priceJ
Offers received
1

Solicitation and notices

Solicitation ID
75N95022Q00204(as reported)
Solicitation date
Apr 21, 2022

Contract details

Subcontracting plan
Plan not requiredB
Service Contract Act labor standards
No
Commercial procedures
Commercial products/servicesA
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Jun 2, 2022Base obligation at award: $68,872
Latest action
Mar 20, 2023 — Supplemental agreement (within scope)Modification P00001
Latest substantive action
Mar 20, 2023 — Supplemental agreement (within scope)Modification P00001
Actions by type
  • Base award1
  • Supplemental agreement (within scope)1
2 actions recorded, Jun 2, 2022 to Mar 20, 2023; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
No
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No

Socio-economic and policy

Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No
Walsh-Healey Act (materials and supplies)
No
Construction wage rates (Davis-Bacon)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Mfg in U.S.D

Structure

Award or IDV
Award
Award type
Purchase orderB
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N950
Transactions recorded under this award key
2

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N95C
Treasury accounts
  • 075-2020/2024-0875-000
Object classes
  • 26.0: Supplies and materials
Disaster or emergency funding (DEFC)
  • N: Emergency P.L. 116-136
COVID-19 supplemental obligations
$68,872
COVID-19 supplemental outlays
$9,229